| Sara Richardson, AGCNS | |
|
310 Sunnyview Ln, Kalispell, MT 59901-3129 | |
| (406) 751-6725 | |
| (406) 758-5170 |
| Full Name | Sara Richardson |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Adult Health |
| Location | 310 Sunnyview Ln, Kalispell, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912655127 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2200X | Clinical Nurse Specialist - Adult Health | 167946 (Montana) | Primary |
| Entity Name | Kalispell Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235333139 PECOS PAC ID: 5294644381 Enrollment ID: O20031122000142 |
News Archive
Stroke is one of the most common neurological disorders worldwide. Many stroke survivors are left with serious health problems. Some patients, for example, find themselves unable to perceive one side of their body and can have problems seeing, hearing and feeling on that side.
It is easier to spread the influenza virus (flu) than previously thought, according to a new University of Maryland-led study released today.
Immunosuppressive regulatory T-cells play an important role in the functioning of adipose tissue. This is the discovery of scientists from the Helmholtz Diabetes Center at Helmholtz Zentrum München and the Technical University of Munich.
Stroke patients prescribed a common antidepressant show no improvement compared with those given a dummy drug, a study has found.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sara Richardson, AGCNS 310 Sunnyview Ln, Kalispell, MT 59901-3129 Ph: (406) 751-6725 | Sara Richardson, AGCNS 310 Sunnyview Ln, Kalispell, MT 59901-3129 Ph: (406) 751-6725 |
News Archive
Stroke is one of the most common neurological disorders worldwide. Many stroke survivors are left with serious health problems. Some patients, for example, find themselves unable to perceive one side of their body and can have problems seeing, hearing and feeling on that side.
It is easier to spread the influenza virus (flu) than previously thought, according to a new University of Maryland-led study released today.
Immunosuppressive regulatory T-cells play an important role in the functioning of adipose tissue. This is the discovery of scientists from the Helmholtz Diabetes Center at Helmholtz Zentrum München and the Technical University of Munich.
Stroke patients prescribed a common antidepressant show no improvement compared with those given a dummy drug, a study has found.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.
› Verified 4 days ago
Susan E Bodurtha, RN, CNS Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 410 Windward Way, Kalispell, MT 59901 Phone: 406-257-1336 Fax: 406-257-1353 | |
Sharon R Androes, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 465 Leisure Dr, Kalispell, MT 59901 Phone: 406-752-3413 |